On June 27, FDA approved a new product – a rapid acting inhaled insulin indicated for the treatment of diabetes call Afrezza. The agency announced the approval by sending out a press release. The agency also sent out this tweet: … Continue reading
In February and in April I posted a listing of upcoming advisory committees by subject matter and people seemed to like this way of looking at it, so I try to repeat it every so often. Today is every so … Continue reading
We sit on the cusp of August – the month when America goes on vacation. Everything will slow down, rush hour will be less rushed, lawns will need less cutting and in our sights is Labor Day which brings the … Continue reading
Last week I held my Webinar on FDA’s Regulation of Social Media called “In More than 140 Characters…” During the 1 hour presentation, I attempted to cover a lot of ground, wanting not only to focus on the latest two … Continue reading
Well, the “poor man’s polar vortex blew through and frankly, while it did make life overall more bearable. But the dogs, the lawn and the flowers all seem happier so that makes it ok by me. I also had my … Continue reading
